Published: Mar-2021 | Format: PDF | Market Research Store | Number of pages: 110 | Code: MRS - 828554
The adhesion barrier market is set for rapid growth over the forecast period. In terms of revenue, the global adhesion barrier market accounted for around USD 690.0 Million in 2019 and is anticipated to reach USD 1120.0 Million by 2026, growing at a CAGR of 7.1%.
An adhesion barrier is a surgical device that helps to prevent irregular internal scarring (adhesions) after surgery by separating internal tissues and organs as they heal. An adhesion barrier is a surgical device, used to prevent adhesion from forming during the procedure. The adhesion barrier is used to distinguish internal tissues and the organ in order to prevent the development of scar tissues known as adhesion. The development of adhesion is caused by damage to the parietal peritoneum or viscera. Adhesion formation may result in chronic pain, miscarriage, and bowel obstruction, both of which are typical surgical risks. When opposed to other operations, abdominal surgery causes a lot of adhesions. Oxidized regenerated cellulose, sodium hyaluronate, expanded polytetrafluoroethylene, and carboxymethylcellulose is used to build the adhesion barriers.
The global demand for adhesion barriers is increasing at a significant rate due to the increase in the hyaluronate of surgeries and sports-related injuries, increasing geriatric population, and rising healthcare expenditures are anticipated to boost the global demand for adhesion barriers within the forecast period. Improvement in healthcare infrastructure and the increasing availability of trauma care centers are anticipated to fuel the growth of the global adhesion barriers in the upcoming years. To fulfill the global adhesion barriers demand, there are technological advancements made to upgrade the adhesion barriers. However, stringent medical device regulations, high surgical costs, and limited awareness of adhesion barriers in developing countries are some of the factors that may hinder the global adhesion barriers market's growth over the forecast period.
The global adhesion barrier market is bifurcated into its type, delivery mode, application, end-user, and regions. Based on the type, the global market is segregated natural adhesion barriers and synthetic adhesion barriers. Natural adhesion barriers are further sub-segmented into collagen & protein, and fibrin. Synthetic adhesion barriers are further sub-segmented into polyethylene glycol, regenerated cellulose, hyaluronic acid, and others. Based on the delivery mode, the market is segmented into gel formulations, film formulations, and liquid formulations. Based on Application, the global market is segmented into general/abdominal surgeries, gynecological surgeries, orthopedic surgeries, urological surgeries, neurological surgeries, cardiovascular surgeries, reconstructive surgeries, and others. Based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and emergency care services. Geographically, the global adhesion barrier market is diversified into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.
North America region dominated the global adhesion barrier market in 2019 and is anticipated to continue its dominance in the upcoming years. The dominance of the North America market can be attributed to the presence of major players such as Baxter International, Johnson and Johnson, FzioMed, Anika Therapeutics, and Integra LifeSciences. The Asia Pacific region is anticipated to grow at the highest rate in the forecast period. The rapidly increasing geriatric population, epidemiological transition from contagious to chronic diseases, improved life expectancy, expansion of private-sector hospitals in rural areas, and increased demand for surgical procedures are all contributing to the region's high growth rate. Furthermore, the demand in the region is projected to be powered by increasing private sector investment in healthcare and rapidly expanding medical tourism. Major countries such as India, China, and Japan are expected to contribute the most to the region's development within the forecast period.
Some of the key players in the adhesion barrier market are Atrium Medical Corporation, Johnson & Johnson, Integra Lifesciences Corporation, Medtronic Plc., Sanofi Group, FzioMed, Inc., Baxter International Inc., Getinge AB, Anika Therapeutics Inc., C. R. Bard, Inc., Becton, Dickinson, and Company, MAST Biosurgery AG., Betatech Medical, Innocoll Holdings, Terumo Corporation, CorMatrix Cardiovascular, Inc., WL Gore & Associates, BiosCompass, Tissuemed Ltd., Allosource, Hangzhou Singclean Medical Products Co., Ltd., and Symatese among others.